Bjerkholt Eric: insider trades.
Bjerkholt Eric reported 7 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($2.2M), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- BJERKHOLT ERIC
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | Officer · CHIEF FINANCIAL OFFICER | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Mirum Pharmaceuticals, Inc. | S | 9,943 | $98.37 | 44,745 | Form 4 |
| 2026-09-11 | Mirum Pharmaceuticals, Inc. | M | 18,333 | — | 54,688 | Form 4 |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. | S | 6,001 | $99.9 | 36,355 | Form 4 |
| 2026-07-06 | Mirum Pharmaceuticals, Inc. | S | 300 | $124.94 | 42,181 | Form 4 |
| 2026-07-06 | Mirum Pharmaceuticals, Inc. | S | 528 | $123.84 | 42,481 | Form 4 |
| 2026-07-06 | Mirum Pharmaceuticals, Inc. | S | 1,048 | $122.43 | 43,009 | Form 4 |
| 2026-07-06 | Mirum Pharmaceuticals, Inc. | S | 3,124 | $121.67 | 44,057 | Form 4 |
Questions
What stock did Bjerkholt Eric buy or sell?
Bjerkholt Eric reported 7 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($2.2M), across 1 company.
Is Bjerkholt Eric the same person as other filers with this name?
This page covers SEC CIK 1197350 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/bjerkholt-eric-1197350.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.